Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus (original) (raw)

References

1. Rickinson, A.B. & Kieff, E. Epstein–Barr Virus. in Fields Virology, Vol. 2 (eds. Knipe, D.M. & Howley, P.M.) 2575–2627 (Lippincott Williams and Wilkins, Philadelphia, 2001).
   Google Scholar
2. Spear, P.G., Eisenberg, R.J. & Cohen, G.H. Three classes of cell surface receptors for alphaherpesvirus entry. Virology 275, 1–8 (2000).
   Article CAS Google Scholar
3. Nemerow, G.R., Mold, C., Schwend, V.K., Tollefson, V. & Cooper, N.R. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein–Barr virus (EBV) to the EBV/C3d receptor of B cells: Sequence homology of gp350 and C3 complement fragment C3d. J. Virol. 61, 1416–1420 (1987).
   CAS PubMed Google Scholar
4. Tanner, J., Weis, J., Fearon, D., Whang, Y. & Kieff, E. Epstein–Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50, 203–213 (1987).
   Article CAS Google Scholar
5. Fingeroth, J.D. et al. Epstein–Barr virus receptor of human B lymphocytes is the C3d complement CR2. Proc. Natl. Acad. Sci. USA 81, 4510–4516 (1984).
   Article CAS Google Scholar
6. Nemerow, G.R., Wolfert, R., McNaughton, M. & Cooper, N.R. Identification and characterization of the Epstein–Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J. Virol. 55, 347–351 (1985).
   CAS PubMed Google Scholar
7. Molesworth, S.J., Lake, C.M., Borza, C.M., Turk, S.M. & Hutt-Fletcher, L.M. Epstein–Barr virus gH is essential for penetration of B cell but also plays a role in attachment of virus to epithelial cells. J. Virol. 74, 6324–6332 (2000).
   Article CAS Google Scholar
8. Miller, N. & Hutt-Fletcher, L.M. A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein–Barr virus. J. Virol. 62, 2366–2372 (1988).
   CAS PubMed Google Scholar
9. Haddad, R.S. & Hutt-Fletcher, L.M. Depletion of glycoprotein gp85 from virosomes made with Epstein–Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. J. Virol. 63, 4998–5005 (1989).
   CAS PubMed Google Scholar
10. Li, Q.X., Turk, S.M. & Hutt-Fletcher, L.M. Epstein–Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J. Virol. 69, 3987–3994 (1995).
    CAS PubMed Google Scholar
11. Wang, X. & Hutt-Fletcher, L.M. Epstein–Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J. Virol. 72, 158–163 (1998).
    CAS PubMed Google Scholar
12. Li, Q.X. et al. Epstein–Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71, 4657–4662 (1997).
    CAS PubMed Google Scholar
13. Haan, K.M., Kwok, W.W., Longnecker, R. & Speck, P. Epstein–Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor. J. Virol. 74, 2451–2454 (2000).
    Article CAS Google Scholar
14. Haan, K.M. & Longnecker, R. Coreceptor restriction within the HLA-DQ locus for Epstein–Barr virus infection. Proc. Natl. Acad. Sci. USA 97, 9252–9257 (2000).
    Article CAS Google Scholar
15. Wang, X., Kenyon, W.J., Li, Q.X., Mullberg, J. & Hutt-Fletcher, L.M. Epstein–Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J. Virol. 72, 5552–5558 (1998).
    CAS PubMed Google Scholar
16. Borza, C.M. & Hutt-Fletcher, L.M. Epstein–Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of the epithelial line SVKCR2. J. Virol. 72, 7577–7582 (1998).
    CAS PubMed Google Scholar
17. Mellman, I., Pierre, P. & Amigorena, S. Lonely MHC molecules seeking immunogenic peptides for meaningful relationships. Curr. Opin. Cell Biol. 7, 564–572 (1995).
    Article CAS Google Scholar
18. Chang, C.H., Fontes, J.D., Peterlin, M. & Flavell, R.A. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatability complex class II genes. J. Exp. Med. 180, 1367–1374 (1994).
    Article CAS Google Scholar
19. Goff, S.P. Retroviridae: The retroviruses and their replication. in Fields Virology, Vol II (eds. Knipe, D.M. & Howley, P.M.) 1871–1939 (Lippincott Williams and Wilkins, Philadelphia, 2001).
    Google Scholar
20. Geraghty, R.J., Jogger, C.R. & Spear, P.G. Cellular expression of alphaherpesvirus gD interferes with entry of homologous and heterologous alphaherpesviruses by blocking access to a shared gD receptor. Virology 268, 147–158 (2000).
    Article CAS Google Scholar
21. Li, Q.X. et al. Epstein–Barr virus infection and replication in a human epithelial system. Nature 356, 347–350 (1992).
    Article CAS Google Scholar
22. Svedmyr, E. et al. Virologic, immunologic, and clinical observations on a patient during the incubation, acute and convalescent phases of infectious mononucleosis. Clin. Immunol. Pathol. 30, 437–450 (1984).
    CAS Google Scholar
23. Callan, M.F. et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein–Barr virus in vivo. J. Exp. Med. 187, 1395–1402 (1998).
    Article CAS Google Scholar
24. Moghaddam, A. et al. An animal model for acute and persistent Epstein–Barr virus infection. Science 276, 2030–2033 (1997).
    Article CAS Google Scholar
25. Van Vooris, W.C. et al. Specific anti-mononuclear antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages. J. Exp. Med. 158, 126–145 (1983).
    Article Google Scholar
26. Takada, K. Cross-linking of cell surface immunoglobulin induces Epstein–Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33, 27–32 (1984).
    Article CAS Google Scholar
27. Yaswen, L.R., Stephens, E.B., Davenport, L.C. & Hutt-Fletcher, L.M. Epstein–Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology 195, 387–396 (1993).
    Article CAS Google Scholar

Download references